A review of progressive multifocal leukoencephalopathy in persons with and without AIDS

Current Clinical Topics in Infectious Diseases

Volumn , Issue 22, 2002, Pages 181-195

  Dworkin, Mark S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; CHILD; EPIDEMIOLOGY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; JC VIRUS; LEUKOENCEPHALOPATHY; MORTALITY; PATHOGENICITY; PRESCHOOL CHILD; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; HIV; HIV INFECTIONS; HUMANS; INFANT; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; SEROEPIDEMIOLOGIC STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036987882     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (118)

1. Eckhart W. Polyomavirinae and their replication. In: Fields BN, Knipe DM, et al., eds. Fundamental virology. 2nd ed. New York: Raven Press Ltd. 1991:727-737.
2. Aksamit Jr. AJ. Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis. Microscopy Research and Technique 1995;32:302-311.
3. Brown P, Tsai T, Gajdusek C. Seroepidemiology of human papovaviruses. Am J Epidemiol 1975;102:331-340.
4. Walker DL, Padgett BL. The epidemiology of human polyomaviruses. In: Sever JL, Madden D, eds. Polyomaviruses and human neurological disease. New York: Alan R. Liss, 1983:99-106.
5. Sadler M, Nelson MR. Progressive multifocal leukoencephalopathy in HIV. Int J STD AIDS 1997;8:351-357.
6. Berger JR, Major EO. Progressive multifocal leukoencephalopathy. Semin Neurol 1999;19: 193-200.
7. Astrom K-E, Mancall EL, Richardson Jr EP. Progressive multifocal leukoencephalopathy. Brain 1958;81:93-111.
8. Henson JW, Louis DN. Edward Peirson Richardson Jr (1918-1998) and the discovery of PML. J Neurovirol 1999;5:325-326.
9. Zu Rhein GM. Polyoma-like virions in a human demyelinating disease. Acta Neuropathol 1967;8: 57-68.
10. Padgett BL, ZuRhein G, Walker D, et al. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971;1:1257-1260.
11. Gordon J, Gallia GL, Del Valle L, et al. Human polyomavirus JCV and expression of myelin genes. J Neurovirol 2000;6(suppl 2):S92-S97.
12. Brooks BR, Walker DL. Progressive multifocal leukencephalopathy. Neurol Clin 1984;2:299-313.
13. Stoner GL, Walker DL, Webster HD. Age distribution of progressive multifocal leukoencephalopathy. Acta . Neurol Scand 1988;78: 307-312.
14. Weber T, Major EO. Progressive multifocal leukencephalopathy: molecular biology, pathogenesis and clinical impact. Intervirol 1997;40: 98-111.
15. Berger JR, Pall L, Lanska D, et al. Progressive multifocal leukencephalopathy in patients with HIV infection. J Neurovirol 1998;4:59-68.
16. Pascual-Sedano B, Iranzo A, Marti-Fabregas J, et al. Prospective study of new-onset seizures in patients with human immunodeficiency virus infection: etiologic and clinical aspects. Arch Neurol 1999;56:609-612.
17. Chadha DS, Handa A, Sharma SK, et al. Seizures in patients with human immunodeficiency virus infection. J Assoc Physicians India 2000;48:573-576.
18. von Einsiedel RW, Fife TD, Aksamit AJ, et al. Progressive multifocal leukencephalopathy in AIDS: a clinicopathologic study and review of the literature. J Neurol 1993;240:391-406.
19. Dalsgaard Hansen NJ, Madsen C, Stenager E. Progressive multifocal leucoencephalopathy. Ital J Neurol Sci 1996;17:393-399.
20. Dörries K, Loeber G, Meixensberger J. Association of polyomaviruses JC, SV40, and BK with human brain tumors. Virology 1987;160:268-270.
21. Weiner LP, Herndon RM, Narayan O, et al. Isolation of virus related to SV40 from patients with progressive multifocal leukencephalopathy. N Engl J Med 1972;286:385-390.
22. Monaco MCG, Jensen PN, Hou J, et al. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 1998;72:9918-9923.
23. Blake K, Pillay D, Knowles W, et al. JC virus associated meningoencephalitis in an immuno-competent girl. Arch Dis Child 1992;67:956-957.
24. Grinnell BS, Padgett BI, Walker DL. Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukencephalopathy. J Infect Dis; 147:669-675.
25. Padgett BL, Walker DL. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 1973;127:467-470.
26. Rhiza HJ, Bornkamm G, ZurHausen H. Seroepidemiological studies and serologic response to viral infection. Med Microbiol Immunol 1978;165:73-92.
27. Major EO, Ault GS. Progressive multifocal leukencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Current Opinion in Neurology 1995;8:184-190.
28. Tomatore C, Berger JR, Houff SA, et al. Detection of JC virus DNA in peripheral lymphocyte from patients with and without progressive multifocal lymphadenopathy. Ann Neurol 1992;31: 454-462.
29. Buckle GJ, Godec MS, Rubi JU, et al. Lack of JC viral genomic sequences in multiple sclerosis brain tissue by polymerase chain reaction. Ann Neurol 1992;32:829-831.
30. Perrons C, Fox J, Lucas S, et al. Detection of polyomaviral DNA in clinical samples from immunocompromised patients: coorelation with clinical disease. J Infect 1996;32:205-209.
31. Mori M, Aoki N, Shimada H, et al. Detection of JC virus in the brains of aged patients without progressive multifocal leukencephalopathy by the polymerase chain reaction and Southern hybridization analysis. Neurosci Lett 1992;141: 151-155.
32. Agostini HT, Brubaker GR, Shao J, et al. BK vims and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania. Arch Virol 1995;140:1919-1934.
33. Ferante P, Caldarelli-Stefano E, Omodeo-Zorini L, et al. Molecular characterisation of JCV strains detected in CSF, PBMcS and urine of AIDS patients with and without PML. XI International Conference on AIDS, Vancouver, Abstracts (MoB 331) 1996.
34. Blumberg BM, Mock DJ, Powers JM, et al. The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach. J Clin Virol 2000;16:159-178.
35. Markowitz RB, Thompson HC, Mueller JF, et al. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and uninfected subjects. J Infect Dis 1993;167:13-20.
36. Knowles WA, Pillay D, Johnson MA, et al. Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol 1999;59:474-479.
37. Coleman DV, Wolfendale MR, Daniel RA, et al. A prospective study of human polyomavirus infection in pregnancy. J Infect Dis 1980;142: 1-8.
38. Berger JR, Kaszovitz B, Donovan Post J, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann Intern Med 1987; 107:78-87.
39. Petito CK, Cho ES, LemannW, et al. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 1986;45:635-646.
40. Dworkin MS, Wan P-CT, Hanson DL, et al. Progressive multifocal leukencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. J Infect Dis 1999;180:621-625.
41. Berger JR, Scott G, Albrecht J, et al. Progressive multifocal leukencephalopathy in HIV-infected children. AIDS 1992;6:837-841.
42. Vandersteenhoven JJ, Dbaibao G, Boyko OB, et al. Progressive multifocal leuloencephalopathy in pediatric acquired immunodeficiency syndrome. Pediatr Infect Dis J 1992;11:232-237.
43. Wrzolek MA, Brudkowska J, Kozlowski PB, et al. Opportunistic infections of the central nervous system in children with HIV infection: report of 9 autopsy cases and review of the literature. Clin Neuropathol 1995;14:187-196.
44. Holman RC, Jannsen RS, Buehler JW, et al. Epidemiology of progressive multifocal leukoen-cephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurology 1991;41:1733-1736.
45. CDC. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:4-19.
46. Selik RM, Karon JM, Ward JW. Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993. J Infect Dis 1997;176: 632-636.
47. Jones JL, Hanson DL, Dworkin MS, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. In: CDC Surveillance Summaries, April 16, 1999. MMWR 1999;48: 1-22.
48. Carpenter CCJ, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults. Updated recommendations of the International AIDS Society-USA panel. JAMA 2000;283:381-390.
49. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338: 853-860.
50. Chowdhury M, Kundu M, Khalili K. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Oncogene 1993;8:887-892.
51. Del Valle L, Croul S, Morgello S, et al. Detection of HIV-1 Tat and JCV capsid protein, VPI, in AIDS brain with progressive multifocal leukencephalopathy. J Neurovirol 2000;6:221-228.
52. Sala M, Vartanian JP, Kousignian P, et al. Progressive multifocal leukencephalopathy in human immunodeficiency virus type 1-infected patients: absence of correlation between JC virus neurovirulence and polymorphism in the transcriptional control region and the major capsid protein loci. J Gen Virol 2001;82:899-907.
53. Port JD, Miseljic S, Lee RR, et al. Progressive multifocal leukencephalopathy demonstrating contrast enhancement on MRI and uptake on thallium-201: a case report. Neuroradiology 1999;41:895-898.
54. Whiteman MLH, Post MJD, Berger JR, et al. Progressive multifocal leukencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993;187:233-240.
55. Arbusow V, Strupp M, Pfister HW, et al. Contrast enhancement in progressive multifocal leukencephalopathy: a predictive factor for long-term survival? J Neurol 2000;247:306-308.
56. Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leucoencephalopathy. Ann Neurol 1998;44:341-349.
57. Post MJD, Yiannoutsos C, Simpson D, et al. Progressive multifocal leukencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? Am J Neuroradiol 1999;20:1896-1906.
58. Collazos J, Mayo J, Martinez E, Blanco MS. Contrast-enhancing progressive multifocal leukencephalopathy as an immune reconstitution event in AIDS patients. AIDS 1999;13:1426-1428.
59. Tomura N, Watanabe M, Kato T, et al. Case report: progressive multifocal leukoencephalopathy with prominent medullary veins on angiogram. Clin Radiol 1994;49:66-68.
60. m HMPAO SPECT in progressive multifocal leucoencephalopathy. Br J Radiol 1992;65:447-449.
61. Iranzo A, Marti-Fabregas J, Domingo P, et al. Absence of thallium-201 brain uptake in progressive multifocal leukencephalopathy in AIDS patients. Acta Neurol Scand 1999;100: 102-105.
62. Zu Rhein GM, Padgett BL, Walker DL, et al. Progressive multifocal leukencephalopathy in a child with severe combined immunodeficiency. N Engl J Med 1978;299:256-257.
63. Gildenberg PL, Gathe Jr. JC, Kim JH. Stereotactic biopsy of cerebral lesions in AIDS. Clin Infect Dis 2000;30:491-499.
64. McGuire D, Barhite S, Hollander H, et al. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive ralue for progressive multifocal leukoencephalopathy. Ann Neurol 1995;37:395-399.
65. De Luca A, Cingolani A, Linzalone A, et al. Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukencephalopathy. J Clin Microbiol 1996;34:1343-1346.
66. Weber T. Cerebrospinal fluid analysis for the diagnosis of human immunodeficiency virus-related neurologic diseases. Sem Neurol 1999;19:223-233.
67. Giancola ML, Tartaglioine T, Ammassari A, et al. Neurological and virologic predictors of survival in AIDS-associated progressive multifocal leukencephalopathy (PML): the role of HAART. Program and abstracts of the XIII International AIDS Conference, July 9-14, 2000; Durban, South Africa. Abstract TuOrB358.
68. Eggers C, Stellbrink HJ, Buhk T, Dorries K. Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukencephalopathy-a longitudinal study. J Infect Dis 1999;180:1690-1694.
69. Weber T, Trebst C, Frye S, et al. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 1997;176:250-254.
70. Guillaume B, Sindic CJM, Weber T. Progressive rnultifocal leukencephalopathy: simultaneous detection of JCV DNA and anti-JCV antibodies in the cerebrospinal fluid. Eur J Neurol 2000;7:101-106.
71. Major EO, Curfman BL. Viral-induced demyelination leading to progressive multifocal leukencephalopathy: the involvement of both immune and nervous system target cells. In: Remington J, Peterson PK, eds. Defense of the brain. Cambridge, MA: Blackwell Science 1997; 305-321.
72. Fong IW, Britton CB, Luinstra KE, et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoenephalopathy. J Clin Microbiol 1995;33:484-486.
73. Levy RM, Russel E, Yungbluth M, et al. The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. Neurosurgery 1992;30:186-189.
74. Kuchelmeistcr K, Cullotta F, Bergmann M, et al. Progressive multifocal leukencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases. Pathol Res Pract 1993;189: 163-173.
75. Domingo P, Guardiola JM, Iranzo A, Margall N. Remission of progressive multifocal leucoencephalopathy after antiretroviral therapy. Lancet 1997;349:1554-1555.
76. Baqi M, Kucharczyk W, Walmsley SL. Regression of progressive multifocal encephalopathy with highly active antiretroviral therapy. AIDS 1997;11:1526-1527.
77. Tassie JM, Gasnault J, Bentata M, et al. AIDS 1999;13:1881-1887.
78. Cinque P, Casari S, Bertelli D. Progressive multifocal leukencephalopathy, HIV, and highlyactive antiretroviral therapy. N Engl J Med 1998; 339:848-849.
79. De Luca A, Letizia Giancola M, Ammassari A, et al. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal lleukencephalopathy J Infect Dis 2000;182:1077-1083.
80. Inui K, Miyagawa H, Sashihara J, et al. Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection. Brain and Development 1999;21:416-419.
81. Gasnault J, Taoufik Y, Goujard C, et al. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal lleukencephalopathyon potent combined antiretroviral therapy. J Neurovirol 1999;5: 421-429.
82. Enting RH, Portegies P. Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukencephalopathy. J Neural 2000;247:134-138.
83. Weiner SM, Laubenberger J, Muller K, et al. Fatal course of HIV-associated progressive mtiltifocal leulcoencephalopathy despite successful highly active antiretroviral therapy. J Infect 2000;40:100-102.
84. th Conference on Retroviruscs and Opportunistic Infections; February 4-8, 2001;Chicago. Abstract 598.
85. Taoufik Y, Dclfraissy JF, Gasnault J. Highly active antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukencephalopathy diagnosis. AIDS 2000;14: 758-759.
86. Clifford DB, Yiannoutsos C, Glicksman M, et al. HAART improves prognosis in HIV-associated progressive multifocal leukonencephalopathy. Neurology 1999;52:623-625.
87. Hou J, Major EO. The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cells line. J Neurovirol 1998;4:451-456.
88. Hall CD, Dafni U, Simpson D, et al. Failure of cytosine arabinoside therapy for human immunodeficiency virus-1 associated progressive multifocal leukencephalopathy: ACTG 243. N Engl J Med 1998;338:1345-1351.
89. Kerr DA, Chang CF, Gordon J, et al. Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology 1993;196:612-018.
90. De Luca A, Giancola ML, Ammassari A, et al. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukencephalopathy. AIDS 2000;14:F117-F121.
91. Meylan PRA, Vuadens P, Maeder P, et al. Monitoring the response of AIDS-related progressive multifocal leukencephalopathy to HAART and cidofovir by PCR for JC virus DNA in the CSF. Eur Neurol 1999;41:172-174.
92. Brambilla AM, Castagna A, Novati R, et al. Remission of AIDS-associated progressive multifocal leukencephalopathy after cidofovir therapy. J Neurol 1999;246:723-725.
93. Portilla J, Boix V, Roman F, et al. Progressive multifocal leukencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy. J Infect 2000;41: 182-184.
94. Blick G, Whiteside M, Griegor P, et al. Successful resolution of progressive multifocal leukencephalopathy after combination therapy with cidofovir and cytosine arabinoside. Clin Infect Dis 1998;26:191-192.
95. th Conference on Retroviruses and Opportunistic Infections; February 4-8,2001;Chicago. Abstract 596.
96. Power C, Nath A, Aoki FY, Del Bigio M. Remission of progressive multifocal leukoencephalopathy following splenectomy and antirctroviral therapy in a patient with HIV infection. N Engl J Med 1997;336:661-662.
97. Power C, Gladden Brown JG, Halliday W, et al. AIDS- and non-AIDS-related PML association with distinct p53 polymorphism. Neurology 2000;54:743-746.
98. Worthmann F, Turkcr T, Muller AR, et al. Progressive multifocal leukencephalopathy after orthotopic liver transplantation. Transplantation 1994;57:1268-1271.
99. Lewis AR, Kline LB, Pinkard NB. Visual loss due to progressive multifocal leukoencephalopathy in a heart transplant patient. J Clin Neuro Ophthalmol 1993;13:237-241.
100. Re D, Bamborschke S, Feiden W, et at. Progressive multifocal leukencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplantation 1999;23:295-298.
101. Mossad SB. Diagnosis: progressive multifocal leukencephalopathy. Clin Infect Dis 2000;31: 15,125-126.
102. Cid J, Revilla M, Genera A, et al. Progressive multifocal leukencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia. Ann Hematol 2000;79:392-395.
103. Ahmed F, Aziz T, Kaufman LD. Progressive multifocal leukencephalopathy in a patient with systemic lupus erythematosus. J Rheumatol 1999;26:1609-1612.
104. Vollmer-Haase J, Young P, Ringelstein EB. Efficacy of camptothecin in progressive multifocal leucoencephalopathy. Lancet 1997;349:1366.
105. Olindo S, Guillon B, Faighel M, Feve JR. Leucoencephalopathie multifocale progressive et sarcoidosepulmonaire. Rev Neurol 2000;156:1013-1016.
106. Kelleher MMB, Galutira D, Duggan TD, Nuovo GJ. Progressive multifocal leukoencephalopathy in a patient with Alzheimer's disease. Diagn Mol Pathol 1994;3:105-113.
107. Aclamek D, Kaluza J, Tomik B, et al. Progressive multifocal leukencephalopathy (PML) in a patient with silicosis treated previously with steroids. A report of a case with JC virus infection confirmed immunohistochemically and by electron microscopy. Pol J Pathol 2000;51:97-101.
108. Haider S, Nafziger D, Guitierrez JA, et al. Progressive multifocal leukencephalopathy and idiopathic CD4+ lymphocytopenia: a case report and review of reported cases. Clin Infect Dis 2000;31:e20-22.
109. Chikezie PU, Greenberg AL. Idiopathic CD4+ T lymphocytopenia presenting as progressive multifocal leukencephalopathy: case report. Clin Infect Dis 1997;24:526-527.
110. Iwase T, Kosei O, Katada E, et al. An unusual course of progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+ T lymphocytopenia. J Neurol Neurosurg Psyciatr 1998;64:788-791.
111. O'Riordan T, Daly PA, Hutchinson M, et al. Progressive multifocal leukencephalopathy - remission with cytarabine. J Infect 1990;20:51-54.
112. Selhorst JB, Ducy KF, Thomas JM, et al. Remission and immmunologic reversals. Neurology 1978;28:337.
113. Berger JR, Mucke L. Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukencephalopathy. Neurology 1988;38:1060-1065.
114. Schlitt M, Morawetz RB, Bonnin J, et al. Progressive multifocal leukencephalopathy; three patients diagnosed by brain. biopsy, with prolonged survival in two. Neurosurgery 1986;18: 407-414.
115. Bauer WR, Turel AP Jr, Johnson KP. Progressive multifocal leukencephalopathy and cytarabine: remission with treatment. JAMA 1973;226:174-176.
116. Marriott PJ, O'Brien MD, Mackenzie IC, Janota I. Progressive multifocal leukoencephalopathy: remission with cytarabine. J Neurol Neurosurg Psychiatry 1975;38:205-209.
117. Houston S, Roberts N, Mashinter L. Failure of cidofovir therapy in progressive multifocal leukencephalopathy unrelated to human immunodeficiency virus. Clin Infect Dis 2001;32: 150-152.
118. Greenlee JE. Progressive multifocal leukoencephalopathy - progress made and lessons relearned. N Engl J Med 1998;338:1378-1380.